SCHEMBL6555897

SCHEMBL6555897

CCOCCN(Cc1ccccc1)c1cc[c]cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
CYP2C19 P33261 1/20 0.42
CNR2 P34972 3/20 0.41
ALDH1A1 P00352 4/20 0.39
NR1H2 P55055 2/20 0.39
NR1H3 Q13133 2/20 0.39
LMNA P02545 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MITF O75030 1/20 0.36
HPGD P15428 1/20 0.36
RAD52 P43351 1/20 0.36
KMT2A Q03164 1/20 0.36
NR3C1 P04150 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
CYP2D6 P10635 1/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553725 0.90 TSHR (0.46) TSHRCYP2C19CNR2ALDH1A1NR1H2
SCHEMBL8015978 0.79 TSHR (0.75) TSHRCYP2C19CNR2ALDH1A1NR1H2
SCHEMBL2103973 0.79 CYP2C19 (0.59) TSHRCYP2C19CNR2ALDH1A1NR1H2
SCHEMBL7565830 0.78 CHRM2 (0.53) TSHRCYP2C19CNR2ALDH1A1LMNA
SCHEMBL8009515 0.78 NR1H2 (0.51) TSHRCYP2C19CNR2NR1H2NR1H3
SCHEMBL2572167 0.77 ALOX15 (0.44) TSHRCYP2C19CNR2ALDH1A1KMT2A
SCHEMBL6555348 0.75 POLB (0.48) TSHRCYP2C19CNR2ALDH1A1LMNA
SCHEMBL11677215 0.74 TSHR (0.52) TSHRCYP2C19CNR2ALDH1A1NR1H2
SCHEMBL8391497 0.74 TSHR (0.50) TSHRCNR2ALDH1A1NR1H2NR1H3
SCHEMBL11978894 0.74 ALDH1A1 (0.47) TSHRCYP2C19CNR2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1234007-B1 OLIGOMERIC METHINE DYES CLARIANT FINANCE BVI LTD (VG) 2004-02-18 EP disclosed
EP-1234007-A1 OLIGOMERIC METHINE DYES Clariant Finance (BVI) Limited (VG) 2002-08-28 EP disclosed
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed
WO-2001036543-A1 OLIGOMERIC METHINE DYES CLARIANT FINANCE (BVI) LIMITED (VG) 2001-05-25 WO disclosed
US-4256458-A DIMERIC PYRIDINIUM DYES BASF AKTIENGESELLSCHAFT (DE) 1981-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC TSHR 3212/4885CYP2C19 1954/4885CNR2 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.